Cajal Neuroscience


Cajal Therapeutics is building innovative solutions in the biotech field, focusing on advancing science and technology. Their website is currently under construction, reflecting their latest developments, team, and future plans.

Industries

biotechnology
neuroscience-e37a
pharmaceutical
therapeutics

Nr. of Employees

medium (51-250)


Products

Target Discovery and Validation Platform

A platform that integrates human genetics, multi-omics, next-generation sequencing, and imaging technologies to identify and validate drug targets for neurodegenerative diseases.

High-Throughput Functional Genomics

A method that uses multiplexed in vitro and in vivo screens to prioritize and validate genes implicated in neurodegenerative diseases.

Lightsheet Microscopy

A 3D imaging technology used to visualize the biological effects of targets or therapeutics in the intact brain, evaluating complex spatial phenotypes.

Sequencing-Based Axon Mapping

A technique that uses sequencing to map axonal projections and understand the spatial organization of the brain.

scRNAseq

Single-cell RNA sequencing used to analyze gene expression at the single-cell level, providing insights into cellular functions and disease mechanisms.

In Vitro Assays

Laboratory tests conducted in controlled environments outside of living organisms to study the effects of drug candidates on cellular models.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.